| View |
|
DRP-13298
|
Loperamide Hydrochloride
|
Golmide
|
2 mg
|
Tablet
|
-
|
Phil. United Pharma Corp.
|
Philippines
|
Initial (OTC)
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13297
|
Ascorbic Acid + Zinc
|
Immunavit-510
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10
mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial (OTC)
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13286
|
Ascorbic Acid + Zinc
|
None
|
500 mg (equivalent to 562.42mg Sodium Ascorbate)/
10 mg
(equivalent to 27.50mg Zinc
Monohydrate)
|
Capsule
|
-
|
Am-Europharma Corporation
|
Philippines
|
Initial [OTC]
|
19 January 2023
|
19 January 2027
|
| View |
|
DRP-13285
|
Ascorbic Acid + Zinc
|
None
|
500 mg (equivalent to 562.42mg Sodium Ascorbate)/
10 mg (equivalent to 27.50mg Zinc Monohydrate)
|
Capsule
|
-
|
Am-Europharma Corporation
|
Philippines
|
Initial [OTC]
|
19 January 2023
|
19 January 2027
|
| View |
|
DR-XY48571
|
Alpha Ketoanalogues + Essential Amino Acids
|
None
|
Each sachet contains:
Calcium-3-methyl-2-oxovalerate (a- Ketoanalogue of isoleucine, Calcium salt) - 201 mg Calcium-4-methyl-2-oxovalerate (a- Ketoanalogue of leucine, Calcium salt) - 303 mg
Calcium-2-oxo-3-phenylpropionate (a-Ketoanalogue of phenylalanine, Calcium salt) - 204 mg
Calcium-3-methyl.2-oxobutyrate (a- Ketoanalogue of valine, Calcium salt) - 258 mg
Calcium-DL-2-hydroxy-4-( methylthio )-butyrate (a-Hydroxy analogue of methionine, Calcium-salt) -
177 mg
L-Lysine Acetate - 315 mg
L-Threonine 159 mg
-
L-Tryptophan - 69 mg
L-Histidine-114 mg
L-Tyrosine 90 mg
Total Nitrogen content I sachet 108mg
Calcium/sachet 3.75 mmol = 150 mg
|
Granules For Oral Solution
|
-
|
Pharose Remedies Limited
|
India
|
Monitored Release
|
24 January 2023
|
24 January 2028
|
| View |
|
DRP-13256
|
Iron
|
FerroSul
|
65 mg (equivalent to 325 mg Ferrous Sulfate Heptahydrate)
|
Film-Coated Tablet
|
-
|
Philippine United Pharma Corp.
|
Philippines
|
Initial [OTC]
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13289
|
Iron + Folic Acid
|
FerroSul Plus
|
60 mg (equivalent to 300 mg Ferrous Sulfate Heptahydrate)/ 250 mcg
|
Film-Coated Tablet
|
-
|
Philippine United Pharma Corp.
|
Philippines
|
Initial [OTC]
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13254
|
Iron
|
Docifer
|
65 mg (equivalent to 325 mg Ferrous Sulfate
Heptahydrate)
|
Film-Coated Tablet
|
-
|
Philippine United Pharma Corp.
|
Philippines
|
Initial [OTC]
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13287
|
Iron + Folic Acid
|
Docifer Plus
|
60 mg (equivalent to 300 mg Ferrous Sulfate
Heptahydrate)/ 250 mcg
|
Film-Coated Tablet
|
-
|
Philippine United Pharma Corp.
|
Philippines
|
Initial [OTC]
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13288
|
Iron + Folic Acid
|
Golfer Plus
|
60 mg (equivalent to 300 mg Ferrous Sulfate
Heptahydrate)/ 250 mcg
|
Film-Coated Tablet
|
-
|
Philippine United Pharma Corp.
|
Philippines
|
Initial [OTC]
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13302
|
Colecalciferol (Vitamin D3)
|
Rani-D
|
1000 IU
|
Softgel Capsule
|
-
|
Kanion Pharmaceutpical Co., Ltd.
|
China
|
Initial (OTC)
|
24 January 2023
|
24 January 2028
|
| View |
|
DRP-13261
|
Sterile Water For Injection
|
Roywat
|
None
|
Solution For Injection
|
Diluent for Parenteral Preparation
|
Royale Life Pharma Inc.
|
Philippines
|
Initial (Variation) (Correction)
|
13 May 2024
|
18 April 2029
|
| View |
|
DRP-13307
|
Rosuvastatin (as Calcium)
|
Rosudex
|
20 mg
|
Film-Coated Tablet
|
-
|
PT Dexa Medica
|
Indonesia
|
Initial
|
24 January 2023
|
24 January 2028
|
| View |
|
DRHR-2198
|
Aceite De Manzanilla
|
None
|
0.2 mL/ 0.1 mL/ 100 mL
|
Topical Solution
|
-
|
Maridan Industries Inc.
|
Philippines
|
Initial
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13262
|
Sterile Water for Injection
|
Roywat
|
N/A
|
Solution For Injection
|
-
|
Royale Life Pharma Inc.
|
Philippines
|
Initial
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13305
|
Diclofenac Sodium
|
Phenylac
|
25 mg/mL
|
Solution For Injection (I.M./I.V.)
|
-
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
Initial
|
23 January 2023
|
23 January 2028
|
| View |
|
DRP-13263
|
0.9% Sodium Chloride
|
Roysal
|
9 mg/mL (0.9%)
|
Solution for Intravenous Infusion.
|
-
|
Royale Life Pharma Inc.
|
Philippines
|
Initial
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13257
|
Sodium Bicarbonate
|
Royalenate®
|
84 mg/mL (8.4% w/v)
|
Solution for Intravenous
Infusion
|
-
|
Royale Life Pharma Inc.
|
Philippines
|
Initial
|
19 January 2023
|
19 January 2028
|
| View |
|
DRP-13250
|
Lidocaine Hydrochloride +
Epinephrine (As Bitartrate),
|
Royaledent®
|
20mg/10mcg per mL
|
Solution For Injection (Local Infiltration)
|
-
|
Royale Life Pharma Inc.
|
Philippines
|
Initial
|
19 January 2023
|
19 January 2028
|
| View |
|
DR-XY48576
|
Ticagrelor
|
None
|
90 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
23 January 2023
|
23 January 2028
|